Compounds > paroxetine

Page last updated: 2024-08-23

paroxetine and Nervous System Diseases

paroxetine has been researched along with Nervous System Diseases in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (22.22)	18.7374
1990's	5 (55.56)	18.2507
2000's	1 (11.11)	29.6817
2010's	1 (11.11)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Claxton, A; Hackett, ML; Hankey, GJ; Hsieh, CF; Kutlubaev, MA; Lee, R; Mead, GE	1
Bertilsson, L; Kytölä, J; Laine, K	1
Brodkin, J; Malyala, A; Nash, JF	1
Cozzi, NV; Frescas, S; Huang, X; Marona-Lewicka, D; Nichols, DE	1
Hoffman, RS; Rella, JG	1
Ackenheil, M; Bottlender, R; Gallinat, J; Hegerl, U; Kuss, HJ; Möller, HJ	1
Max, MB	1
Johnson, MP; Nichols, DE	1
Hekmatpanah, CR; McKenna, DJ; Peroutka, SJ	1

Reviews

1 review(s) available for paroxetine and Nervous System Diseases

Article	Year
Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. The Cochrane database of systematic reviews, 2012, Nov-14, Volume: 11 Topics: Adult; Anxiety; Citalopram; Cognition; Depression; Fluoxetine; Humans; Nervous System Diseases; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Stroke; Stroke Rehabilitation	2012

Other Studies

8 other study(ies) available for paroxetine and Nervous System Diseases

Article	Year
Severe adverse effects in a newborn with two defective CYP2D6 alleles after exposure to paroxetine during late pregnancy. Therapeutic drug monitoring, 2004, Volume: 26, Issue:6 Topics: Alleles; Cytochrome P-450 CYP2D6; Female; Humans; Infant, Newborn; Nervous System Diseases; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects	2004
Effect of acute monoamine depletion on 3,4-methylenedioxymethamphetamine-induced neurotoxicity. Pharmacology, biochemistry, and behavior, 1993, Volume: 45, Issue:3 Topics: 3,4-Methylenedioxyamphetamine; alpha-Methyltyrosine; Animals; Axons; Biogenic Monoamines; Brain Chemistry; Designer Drugs; Dialysis; Dopamine; Fenclonine; Male; Methyltyrosines; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Endings; Nervous System Diseases; Paroxetine; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin; Stereotaxic Techniques; Tyrosine 3-Monooxygenase	1993
Indan analogs of fenfluramine and norfenfluramine have reduced neurotoxic potential. Pharmacology, biochemistry, and behavior, 1998, Volume: 59, Issue:3 Topics: Animals; Appetite Depressants; Body Weight; Brain Chemistry; Discrimination, Psychological; Fenfluramine; In Vitro Techniques; Indans; Male; Nervous System Diseases; Neurotransmitter Uptake Inhibitors; Norfenfluramine; Paroxetine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Serotonin; Synaptosomes	1998
Possible serotonin syndrome from paroxetine and clonazepam. Journal of toxicology. Clinical toxicology, 1998, Volume: 36, Issue:3 Topics: Adult; Clonazepam; Contraindications; Drug Interactions; Female; GABA Modulators; Humans; Nervous System Diseases; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Syndrome	1998
The serotonin syndrome scale: first results on validity. European archives of psychiatry and clinical neuroscience, 1998, Volume: 248, Issue:2 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Evoked Potentials, Auditory; Female; Humans; Male; Middle Aged; Nervous System Diseases; Neurologic Examination; Paroxetine; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptic Transmission; Syndrome	1998
Towards physiologically based treatment of patients with neuropathic pain. Pain, 1990, Volume: 42, Issue:2 Topics: Analgesics; Animals; Clinical Trials as Topic; Humans; Nervous System Diseases; Pain; Pain Measurement; Palliative Care; Paroxetine; Piperidines	1990
Neurotoxic effects of the alpha-ethyl homologue of MDMA following subacute administration. Pharmacology, biochemistry, and behavior, 1989, Volume: 33, Issue:1 Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Biogenic Monoamines; Brain Chemistry; Hydroxyindoleacetic Acid; Male; N-Methyl-3,4-methylenedioxyamphetamine; Nervous System Diseases; Norepinephrine; Paroxetine; Piperidines; Rats; Rats, Inbred Strains; Serotonin	1989
Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced neurotoxicity in the rat. Neuroscience letters, 1989, Sep-25, Volume: 104, Issue:1-2 Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Cerebral Cortex; Corpus Striatum; Designer Drugs; Dopamine; Male; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Endings; Nervous System Diseases; Paroxetine; Piperidines; Rats; Rats, Inbred Strains; Reserpine; Serotonin	1989